Patents by Inventor Robin Willows

Robin Willows has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Direct AMPK activator compounds
    Patent number: 11583507
    Abstract: The present invention relates to a compound having general formula I for use in the activation of AMPK. A composition comprising said compound for use in the activation of AMPK is also provided. Said compounds are 9,10 dihydrophenanthrenes, in particular selected from the group consisting of: (i) Lusianthridin i.e. 7-Methoxy-9,10-dihydrophenanthrene-2,5-diol, (ii) 7-Methoxy-9,10-dihydrophenanthrene-2,3,5-triol, (iii) 9,10-dihydrophenanthrene-2,5-diol, (iv) 9,10-Dihydrophenanthrene-2,4,7-triol (v) 9,10-Dihydro-7-methoxy-3,5-phenanthrenediol, and the activation of AMPK improves the condition, disorder, or disease related to cardiometabolic health, obesity, type 2 diabetes, non-alcoholic fatty liver disease, cardiovascular disease, and cancer.
    Type: Grant
    Filed: May 15, 2019
    Date of Patent: February 21, 2023
    Assignee: Societe des Produits Nestle S.A.
    Inventors: Denis Marcel Barron, Yann Ratinaud, Kei Sakamoto, Matthew Sanders, Robin Willows
  • USE OF GREEN COFFEE BASED COMPOSITIONS FOR IMPROVING INSULIN PROFILE
    Publication number: 20220175864
    Abstract: The present invention relates to a green coffee-based composition comprising hydrolysed chlorogenic acid for use in the treatment or prevention of a disorder linked to an increase in plasma postprandial insulin in a subject. The invention relates also to the non-therapeutic use of a composition comprising an esterase treated decaffeinated green coffee extract with an amount of 40-200 mg administered to a subject per day to decrease plasma postprandial insulin concentration. A further aspect of the invention is a process for forming green coffee based compositions.
    Type: Application
    Filed: March 27, 2020
    Publication date: June 9, 2022
    Inventors: Lucas Actis Goretta, Jacklyn Ruilin Chen, Rachid Bel-Rhlid, Robin Willows, Marine Kraus, Christian Chabert
  • DIRECT AMPK ACTIVATOR COMPOUNDS
    Publication number: 20210038536
    Abstract: The present invention relates to a compound having general formula I for use in the activation of AMPK. A composition comprising said compound for use in the activation of AMPK is also provided. Said compounds are 9,10 dihydrophenanthrenes, in particular selected from the group consisting of: (i) Lusianthridin i.e. 7-Methoxy-9,10-dihydrophenanthrene-2,5-diol, (ii) 7-Methoxy-9,10-dihydrophenanthrene-2,3,5-triol, (iii) 9,10-dihydrophenanthrene-2,5-diol, (iv) 9,10-Dihydrophenanthrene-2,4,7-triol (v) 9,10-Dihydro-7-methoxy-3,5-phenanthrenediol, and the activation of AMPK improves the condition, disorder, or disease related to cardiometabolic health, obesity, type 2 diabetes, non-alcoholic fatty liver disease, cardiovascular disease, and cancer.
    Type: Application
    Filed: May 15, 2019
    Publication date: February 11, 2021
    Inventors: Denis Marcel Barron, Yann Ratinaud, Kei Sakamoto, Mattew Sanders, Robin Willows